Javelin gets Hospira loan and court date
This article was originally published in Scrip
Executive Summary
Hospira has agreed to pay a $2 million loan to its acquisition target Javelin Pharmaceuticals on 10 June, after the latter launched a lawsuit claiming Hospira had breached the terms of their merger agreement. Under the agreement, Hospira was to pay Javelin up to $4 million in monthly instalments of up to $2 million each to cover working capital and general corporate purposes.